Director at Duke Robotics (DUKR) awarded 4,000 stock options

Rhea-AI Filing Summary

DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Golan Keren Gousman

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	4,000	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock — 4,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Golan Keren Gousman

(Last) (First) (Middle)

C/O DUKE ROBOTICS CORP.

10 HARIMON STREET

(Street)

MEVO CARMEL SCIENCE & IND PARK L3 2069203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUKE Robotics Corp. [ DUKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$7.88	03/10/2026		A		4,000(1)		(1)	03/10/2032	Common Stock	4,000	$0	4,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on March 10, 2027.

	/s/ Keren Gousman Golan	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DUKE Robotics (DUKR) report for Golan Keren Gousman?

DUKE Robotics reported that director Golan Keren Gousman received an option grant for 4,000 shares of common stock. The options were awarded at an exercise price of $7.88 per share and represent a compensation-related acquisition, not an open-market stock purchase or sale.

What are the key terms of the 4,000-share stock option granted by DUKE Robotics (DUKR)?

The grant covers options to buy 4,000 DUKE Robotics common shares at an exercise price of $7.88 per share. These derivative securities expire on March 10, 2032, providing the director a long-dated right to purchase shares at that fixed price if the options vest.

How does the vesting schedule work for the DUKE Robotics (DUKR) option grant?

The 4,000-share option grant vests in three equal annual installments beginning on March 10, 2027. This means roughly one-third of the options become exercisable each year, aligning the director’s potential ownership with longer-term service and performance at DUKE Robotics.

Is the DUKE Robotics (DUKR) Form 4 transaction a stock purchase or a compensation award?

The Form 4 transaction is a compensation award, not a market purchase. It records a grant of options to buy 4,000 shares at $7.88 per share, with no cash changing hands now. The director may choose to exercise the options in the future after vesting.

How many DUKE Robotics (DUKR) options does the director hold after this Form 4 transaction?

After the reported transaction, the director holds 4,000 options to purchase DUKE Robotics common stock directly. These options are subject to the vesting schedule starting on March 10, 2027 and expiring on March 10, 2032, as disclosed in the filing data.